Ghayas Issa

103PUBLICATIONS

256CO-AUTHORS

Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (103)

Sort by Publication Date:

|Jun 22, 2026

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|Jun 11, 2026

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|Jun 02, 2026

Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

|May 27, 2026

Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|Mar 20, 2026

Mutations in isocitrate dehydrogenase portend a poor prognosis in adult patients with acute lymphoblastic leukemia.

Hannah Goulart, Nicholas J Short, Gautam Borthakur

|Mar 12, 2026

Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

Pageof 18

Frequent Collaborators

67 joint publications

Courtney DiNardo

59 joint publications

Navel G Daver

58 joint publications

Nicholas Short

54 joint publications

Hagop M Kantarjian

51 joint publications

Elias Jabbour

49 joint publications

Tapan M Kadia

48 joint publications

Farhad Ravandi

42 joint publications

Koji Sasaki

41 joint publications

Gautam Borthakur

40 joint publications

Sanam Loghavi